What's new in contact dermatitis: allergy to topical steroids in Israeli patients with contact dermatitis.
Ingber
Arieh
A
Department of Dermatology, Hadassah University Hospital, Hebrew University Medical School, Jerusalem, Israel. fjonas@hadassah.org.il
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D003876:Dermatitis, Atopic / Q000150:complications*; D003877:Dermatitis, Contact / Q000150:complications* / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000209:etiology*; D017575:Gloves, Protective / Q000009:adverse effects; D006801:Humans; D006854:Hydrocortisone; D006969:Hypersensitivity, Immediate / Q000139:chemically induced; D007557:Israel; D020315:Latex Hypersensitivity / Q000209:etiology; D010328:Patch Tests; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects; D013849:Thimerosal / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal; D006854:Hydrocortisone